Skip to main content

Table 1 Baseline patient characteristics and MR-proANP plasma concentrations

From: Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients

Parameter

All patients

Non-sepsis

Sepsis

Number

217

73

144

Sex (male/female)

133/84

48/25

85/59

Age median (range) [years]

64 (18–90)

61 (18–85)

65 (20–90)

APACHE-II score median (range)

18 (2–43)

13.5 (2–33)

19 (4–43)

SOFA score median (range)

9 (0–19)

7.0 (0–17)

9.5 (2–19)

SAPS2 score median (range)

41 (0–73)

41.0 (13–72)

40.5 (0–73)

ICU days median (range)

7 (1–137)

6 (1–45)

9 (1–137)

Death during ICU n(%)

46 (21.2%)

9 (12.3%)

37 (25.7%)

Death overall (total) n(%)

86 (39.6%)

22 (30.1%)

64 (44.4%)

Mechanical ventilation n(%)

144 (66.4%)

46 (63%)

98 (67%)

Preexisting diabetes n(%)

65 (30.0%)

22 (30.1%)

43 (29.9%)

BMI median (range) [m2/kg]

26.0 (15.3–86.5)

25.7 (15.9–40.5)

26.0 (15.3–86.5)

WBC median (range) [×103/µl]

12.9 (0.1–208)

12.5 (1.8–29.6)

13.8 (0.1–208)

CRP median (range) [mg/dl]

103.0 (5–230)

17 (5–230)

163.5 (5–230)

IL-6 median (range) [pg/ml]

145.0 (2–28,000)

66.5 (1.5–5000)

240 (2–28,000)

Procalcitonin median (range) [pmol/l]

0.7 (0.03–207.5)

0.2 (0.03–100)

1.8 (0.03–207.5)

Creatinine median (range) [mg/dl]

1.3 (0.1–15)

1.0 (0.2–15)

1.6 (0.1–10.7)

INR median (range)

1.16 (0.92–13)

1.17 (0.95–6.73)

1.16 (0.92–13)

MR-proANP day 1 median (range) [pmol/l]

214.0 (2.1–3417.0)

147.2 (2.1–1625.0)

246.6 (7.8–3417.0)

  1. For quantitative variables, median and range (in parenthesis) are given